Received: from intelliclaim.com [66.65.120.27] by aifarms.com with ESMTP
  (SMTPD32-6.06) id A810FEE0132; Fri, 09 Aug 2002 12:29:20 -0700
From: intelliclaimnews@intelliclaim.com
To: radon@kzsu.stanford.edu
Subject: intelliClaim newsletter 08.02.02
Date: 09 Aug 2002 15:29:19 -0400
Expiry-Date: 09 Aug 2003 14:33:34 -0400
MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_kymKzPFE_OQL8qx8a_MR"
Message-Id: <200208091229387.SM01424@intelliclaim.com>
X-RCPT-TO: <dave@aifarms.com>
X-UIDL: 351722483
Status: R


------=_kymKzPFE_OQL8qx8a_MR
Content-Type: multipart/alternative; boundary="----=_S96xdKnA_yxlVaFWs_MA"


------=_S96xdKnA_yxlVaFWs_MA
Content-Type: text/plain
Content-Transfer-Encoding: 8bit

intelliClaim news 
08.02.02
  
Contents
  Note from Kevin
  Customer Update 
  IntelliClaim People 
  Customer Q&A 
  IntelliClaim POV 
  IntelliClaim in the News  

  
Note from Kevin
---------------
  
Dear Friend:

IntelliClaim News is intended as a resource of ideas that can help you with 
the challenges you face daily and assist you in making the most of your 
relationship with IntelliClaim. Here, you’ll learn about the situations 
faced by other members of the IntelliClaim client community, solutions 
developed to address those challenges, and about additions to our growing 
professional staff. We will also look for your participation by offering 
questions and comments that might be of interest to others. 

Our industry is changing rapidly, and it is important that we all continue 
to refine our knowledge to address the pressures that arise daily from the 
market, the regulatory environment, and the provider community. Sharing 
what we learn, and articulating effectively why our organizations make the 
payment decisions we do will lead us to the consistent and defensible 
positions that represent the kind of best practice we aspire to. I hope you 
will find IntelliClaim News both interesting and useful. If you have 
questions or suggestions, please send us your comments at 
intelliclaimnews@intelliclaim.com, or contact me directly.

Thanks for your continued support,

Kevin Hickey - Chairman and CEO
 

Customer Update
---------------
 
Since IntelliClaim was founded in 1998, we have worked with more than 20 
managed care payor organizations of all sizes, helping them develop 
solutions specific to their business needs. Recently, we welcomed two new 
members to the IntelliClaim customer community.

Anthem West, part of the Anthem, Inc., system of Blue Cross/Blue Shield 
plans, has signed on with IntelliClaim. In addition to our claim editing 
services, IntelliClaim will be working with Anthem to offer direct access 
to rule justification for members of their provider network – customized 
through Anthem’s own website. We expect the program to be up and running 
within 90 days.

Montefiore Healthplans, a provider-owned organization covering 135,000 
lives in the New York Metropolitan area, has engaged IntelliClaim for our 
full suite of solutions, including "roundtrip" integration of 
IntelliClaim’s technology with their claims processing system. With a 
commitment to meet a tight schedule, Montefiore was up and running in just 
60 days.

If you’d like to learn more about client solutions we have available, and 
how they might be customized for your needs, please contact Ed Brennan, 
ebrennan@IntelliClaim.com, 203-750-5145.
 

IntelliClaim Welcomes New Chief Medical Officer and Data Analyst
----------------------------------------------------------------
 
In June, we were proud to welcome Dr. Bruce Campbell as IntelliClaim’s new 
Chief Medical Officer. Dr. Campbell will work with our clients to identify 
opportunities to improve their claims policies, to make the most of 
IntelliClaim’s technology to enhance their decision-making and to 
communicate their claims processes to providers.

"IntelliClaim’s strategic approach and the depth of the company’s high-tech 
solutions appear to offer a great opportunity to secure higher efficiencies 
and strong provider relations throughout the industry," Dr. Campbell said. 
"I am delighted to be asked to participate in this effort, and I look 
forward to working closely with Kevin and my new colleagues."

Dr. Campbell brings to IntelliClaim the experience and insight gained 
during a distinguished career in health benefits and medical management. 
Between 1994 and 1997, he held several executive positions with Aetna, 
Inc., including Senior Vice President of Aetna US Healthcare and Chief 
Medical Officer of Aetna Health Plans. Dr. Campbell served as Vice 
President for Medical Programs at ScrippsHealth and was President of 
Monsanto Health Solutions. Most recently, he served as President and CEO of 
Camber Companies, a multi-disciplinary musculoskeletal ambulatory treatment 
center business.

"Bruce’s energy and expertise are a terrific asset for IntelliClaim’s 
clients," said CEO Kevin Hickey, "and his addition to the senior team is an 
important milestone in the growth of our business."

This month also saw the addition of Daniel Sherman as data analyst at 
IntelliClaim. As a data analyst, his primary responsibility is as a liaison 
between the client’s and the technical areas within IntelliClaim. A 
business systems professional with deep experience in the managed care 
environment, Dan joins IntelliClaim from HealthNet of the Northeast, one of 
the largest regional health plans serving over one million members.
 
 
Questions From Our Customers 
----------------------------

Q. Our providers often request additional information on clinical 
justifications for claim denials or adjustments. Where can we get this 
information?
 
A. While details on clinical justifications are typically provided by the 
source of the rule or edit, access can be complicated. Individual vendors 
or associations may provide access to this information, but it may only be 
through a proprietary network or made available by doing further research. 
For example, in the case of the CMS CCI edits, justifications are available 
but the information may not be readily available or may reference other CMS 
publications, such as its carrier’s manual or numerous other program 
memoranda.

At IntelliClaim, we maintain a database of the justifications aggregated 
from all of our various content sources – critical information that can be 
easily accessed by our customers through the Internet. You can also quickly 
forward this data or provide web access to either your own staff or to the 
interested provider.
 

Q: Our current corporate structure allows medical directors in each of our 
regions to modify payment policies to conform to regional standards. How 
can we accurately process claims that allow for such variation?

A: As payor organizations continue to grow, regional variations in payment 
policies will become even more complex, and have a greater impact on the 
bottom line. Indeed, once the variations are understood, your data may 
require customization at the level of payment logic to make the rules 
consistent overall, but also sensitive to regional differences.

Fortunately, IntelliClaim’s customized solutions approach is designed 
precisely for these increasingly important market factors. In one instance, 
IntelliClaim worked with the payor organization to analyze the payment 
policy of each region. After interviewing each medical director, 
IntelliClaim identified those rules requiring customization in each region, 
and then proceeded to implement through a technology solution that assured 
accuracy without manual intervention. The result for our customer: fewer 
appeals, less expensive reprocessing. And, as a significant additional 
benefit, regional variations were documented and authorized within the 
client's medical payment policy, thus providing a repository for policies 
and the exceptions, including a full audit trail of the origin and final 
decision.
 

Q: Is there a way to study the impact of a new rule before we decide to 
implement the rule in our processing system? Although we're looking for 
additional cost savings, I'm cautious about the possible impact a new rule 
may have on some of our providers. 

A: IntelliClaim customers have the ability to run a newly configured rule 
against existing claims data without the outcomes of these new rules being 
applied against the claim. At the same time, these outcomes are made 
available in a database against which reports can be generated, giving our 
client’s the ability to study the financial impact as well as the impact on 
specific providers, specialties, procedure codes, or any other attributes 
on the claim. 

If you would like more information related to any of these questions, 
please contact Sandy Slowik at sslowik@intelliclaim.com, or call 203-750-
5147.
 
POV: Focusing on Transparency: A Defining Trend
-----------------------------------------------
 
Today, all medical claims payors face a common challenge – they must 
provide clear and consistent justification of claims administration so that 
both providers and consumers can better understand the actions taken by 
payors. The payors must demonstrate to consumers, providers and 
policymakers that they have a solid commitment to consistent and accurate 
processing of claims.

For this reason, providers often feel that they are kept in the dark about 
how a payor will ultimately decide which procedures to pay and which to 
deny. While remittance from a payor might provide a clear indication of 
what has been denied, the justification for that denial is not always 
clearly conveyed to a provider. Some providers will not accept the 
application of correct coding practices, regardless of the degree of 
justification or support, but the vast majority are accepting of payor 
decisions that are made with a thoughtful rationale and with consistent 
application.

Communicating the rationale for payment decisions is not always a simple 
capability for a payor to enable. Payors with system constraints struggle 
with the best way to communicate their payment decisions to providers. 
Legacy claims systems do not always allow for flexibility in applying 
payment methodologies that take provider contracts into account. Moreover, 
communicating the outcomes of claims editing (such as "bundling") often 
requires that the procedure be denied first, an instance further 
complicated by the need to draw additional supporting documentation from 
sources external to the claims processing system.

Industry trends, evolving state legislation (e.g., Georgia, Texas, New 
Jersey, New York, Colorado), and recent ERISA regulations indicate that 
these issues will only become more difficult. As payor organizations 
expand, state by state policy issues come into play, complicating the 
nature of information and how it can be shared. In addition to providing 
clearer direction and justification as to how a payor has reimbursed a 
claim, payors are being required to provide disclosure of those payment 
methodologies in advance.

More is at stake in this "transparency" issue than simple administrative 
efficiencies. At IntelliClaim, we believe that better communication of 
claims decisions and justifications are crucial for enhancing provider 
relations and, ultimately, strengthening the image of our industry among 
consumers and policymakers.

At IntelliClaim these emergent transparency issues are very much top-of-
mind. Through both our advanced technology – grounded in the latest rules-
based science of applied artificial intelligence – and our consulting 
services that support payor organizations at all levels, IntelliClaim looks 
for the smartest solutions, and the clearest path to productive 
transparency for our clients.
 
Intelliclaim in the News
------------------------
 
Recent press coverage on an effort we have underway to enhance fraud and 
abuse detection with one of our clients, from ADVANCE for HEALTH 
INFORMATION EXECUTIVES. http://www.advanceforhie.com/hxMCO.html 

MCO Update: Fraud and Abuse Detection
by Robert Mitchell

Health plans regularly monitor physician-billing practices, often catching 
fraudulent activities after a claim has been paid. But health plans are now 
looking to catch these activities before it costs them any money. Health 
plans view this as a preventive solution that could reduce fraudulent 
activity from occurring in the first place.

What is fraud?

Grace Mary Altkin, manager of cost containment at Vytra Health Plans, a 
200,000-member plan with 6,000 physicians and 38 hospitals on Long Island, 
said her company wanted to capture fraudulent activity before the health 
plan paid out any money. The health plan, which is piloting a fraud 
detection system by HNC Software of San Diego through a project with 
IntelliClaim, said it is exchanging data with HNC and has already gotten 
initial favorable results that could save money. "We have a fraud unit here 
and are identifying claims that need to be reviewed," Altkin said. "We're 
confident that we have the right systems and procedures in place, but there 
still may be some leakage . . . We want to identify any gaps, identify any 
trends and see if we can put in additional procedures to prevent us from 
paying incorrectly on fraudulent items or in paying incorrectly on abusive 
billing practices."

Gayle Esposito, a senior investigator in Vytra's special investigative 
unit, said determining if a claim is fraudulent requires the health plan to 
look at whether the provider's actions constituted a legitimate mistake, 
neglect or actual fraud. "I look for trends," she said. "We regularly use 
adjustment codes and our provider relations representatives educate the 
providers; if a provider continues to do something he or she has been told 
not to do, then we feel the provider has crossed the line."

Andrea Allmon, PhD, product director of HNC's predictive health care group, 
said, "There are providers who are genuinely good-hearted individuals, who 
want to maximize their clinic or office revenues so they may up-code a 
claim here or there. There are also providers who want to care for their 
patients but, because of perceived constraints on what insurance companies 
pay, might disguise a service so the insurance company pays for something 
that might not otherwise be covered."

Akshay Gupta, chief business development officer at IntelliClaim, said the 
question of intent is always considered in reviewing whether a claim should 
be reimbursed or whether fraud or abuse occurred, or whether it was simply 
an error or oversight. "A lot of errors occur because of the way the health 
insurance industry works; it's extremely complicated. And when a provider 
works with many different health plans, each with its own set of rules on 
how to bill and what can be billed, it can be confusing. Physicians 
sometimes bill for everything they can and let the health plan sort it out,
" Gupta said. "We help health plans deal with that complexity more 
effectively today, and through HNC's sophisticated software will now be 
able to help them by proactively identifying abusive or fraudulent 
behavior."

Steve Biafore, vice president of HNC Software's predictive health care 
group, noted that the General Accounting Office has said that managed care 
fraud and abuse is difficult to solve and, "it's commonly understood that 
there is about three percent hard-core fraud, to well over 10 to 14 percent 
losses due to fraud." 

This is alarming because the government has projected national health 
expenditures to total $1.4 trillion and reach 13.4 percent of the Gross 
Domestic Product each year, according to National Health Care Expenditures 
Projections: 2000-2010 from the Office of the Actuary at the Center for 
Medicare and Medicaid Services. 

Risky claims

Analysis information provided by HNC to Vytra includes a claim's risk 
score. HNC also supplies an explanation of why a particular claim may be 
considered risky. "A claim may be a risk because the provider's procedure 
mix is radically different from other providers or for other reasons," 
Allmon said. 

After a claim has been identified as risky, there are a couple of scenarios 
that can occur. "First, investigators can decide to pay the claim and watch 
what the provider does. Or, they can simply deny the claim," Allmon said. 
"They could also suspend the claim, request further information, or deny 
the claim and investigate further, thus possibly leading to prosecution of 
the provider." 

Mr. Mitchell is senior associate editor of ADVANCE for Health Information 
Executives.


------=_S96xdKnA_yxlVaFWs_MA
Content-Type: text/html
Content-Transfer-Encoding: 8bit

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">

<html>
<head>
	<title>intelliClaim news 08.02.02</title>
	<style>
	P.main {
		margin : 12px 15px 12px 15px;
		font-family : Helvetica, sans-serif;
		font-size : x-small;
	}
	P.subhead {
		margin : 12px 15px 12px 15px;
		font-weight : bold;
		font-family : Helvetica, sans-serif;
		font-size : x-small;
	}
	P.question {
		margin : 12px 15px 0px 15px;
		font-weight : bold;
		font-family : Helvetica, sans-serif;
		font-size : x-small;
	}
	P.qa {
		margin : 15px 5px 12px 15px;
	}
	P.head {
		margin : 6px 15px 6px 15px;
		color : White;
		font-weight : bold;
		font-family : Helvetica, sans-serif;
		font-size : x-small;
	}
	P.small {
		margin : 0px 15px 11px 15px;
		color : White;
		font-weight : bold;
		font-family : Helvetica, sans-serif;
		font-size : "9px";
	}
	P.date {
		margin : 6px 15px 9px 15px;
		color : White;
		font-weight : bold;
		font-family : Helvetica, sans-serif;
		font-size : "12pt";
	}
	P.margin {
		margin : 6px 20px 2px 12px;
		color : #03A9E2	;
		font-family : Helvetica, sans-serif;
		font-size : 9;
	}

	A.margin {
		margin : 6px 15px 6px 12px;
		color : #03A9E2	;
		font-family : Helvetica, sans-serif;
		font-size : "8pt";
	}
	A {
		color : #03A9E2	;
	}
</style>
</head>

<body bgcolor="#FFFFFF" leftmargin="72" topmargin="84" rightmargin="72" bottommargin="84" marginwidth="72" marginheight="84" margin="">
<table bgcolor="#FFFFFF" width="620" cellspacing="0" cellpadding="0" border="1" bordercolor="#666666" frame="box"><tr><td>
	<table width="620" border="0" cellspacing="0" cellpadding="0" >
	<tr>
	<td colspan="2" valign="top" width="381"><img src="http://www.aifarms.com/intelliclaim/newsletter/intelliclaim_news_banner.jpg" width="380" height="91" alt="intelliClaim news" border="0"></td>
	<td valign="bottom" width="100%" bgcolor="#777777">
		<p class="date">08.02.02</p>
		</td><td bgcolor="#777777" valign="bottom"><a href="http://www.intelliclaim.com"><img src="http://www.aifarms.com/intelliclaim/newsletter/intelliClaim_logo_grey2.gif" width="97" height="38" alt="intelliClaim" border="0"></a></td>
	</tr>
	<tr><td><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="3" alt="" border="0"></td></tr>
</table>
<table bgcolor="#FFFFFF" width="620" cellspacing="0" cellpadding="0" border="0">
	<tr>
	<td valign="bottom" align="right">
		<p class="margin" align="left">Contents</p><img src="http://www.aifarms.com/intelliclaim/newsletter/grey1x1.gif" width="128" height="1" alt="" border="0"></td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td colspan="2" valign="top">
		<table cellspacing="0" cellpadding="0" cellspacing="0"width="100%">
		<tr width="100%">
		<td bgcolor="#7FC31C" width="100%" valign="top"><a name="note_from_kevin"><p class="head">Note from Kevin</p></td>   
		</tr>
		</table>
	</td>
	</tr>
	<tr>
	<td valign="top">
		<table width="140" border="0" cellspacing="0" cellpadding="1">
		<tr><td valign="top">
		<a class="margin" href="#note_from_kevin">Note from Kevin</a>
		<a class="margin" href="#customer_update">Customer Update</a>
		<a class="margin" href="#intelliclaim_people">IntelliClaim People</a>
		<a class="margin" href="#customer_qa">Customer Q&amp;A</a>
		<a class="margin" href="#intelliclaim_pov">IntelliClaim POV</a>
		<a class="margin" href="#intelliclaim_in_the_news">IntelliClaim in the News</a>
		</td></tr>
		</table> 
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td colspan="2">
		<table cellspacing="0" cellpadding="0" width="100%">
		<tr>
		<td width="100%">
<p class="main">Dear Friend:</p>

<p class="main"><font style="font: bold italic;">IntelliClaim News</font> is intended as a resource of ideas that can help you with the challenges you face daily and assist you in making  the most of your relationship with IntelliClaim. Here, you’ll learn about the situations faced by other members of the IntelliClaim client community, solutions developed to address those challenges, and about additions to our growing professional staff. We will also look for your participation by offering questions and comments that might be of interest to others. 
</p>

<p class="main">Our industry is changing rapidly, and it is important that we all continue to refine our knowledge to address the pressures that arise daily from the market, the regulatory environment, and the provider community. Sharing what we learn, and articulating effectively why our organizations make the payment decisions we do will lead us to the consistent and defensible positions that represent the kind of best practice we aspire to.  I hope you will find <font style="font: bold italic;">IntelliClaim News</font> both interesting and useful. If you have questions or suggestions, please send us your comments at <a href="mailto:intelliclaimnews@intelliclaim.com" >intelliclaimnews@intelliclaim.com</a>, or contact me directly.</p>

<p class="main">Thanks for your continued support,</p>

<p class="main"><font style="font: bold;">Kevin Hickey</font> - Chairman and CEO</p>
		</td>   
		</tr>
		<tr width="100%">
		<td bgcolor="#777777" width="100%"><a name="customer_update"><p class="head">Customer Update</p></td>   
		</tr>
		<tr>
		<td width="100%">
<p class="main">Since IntelliClaim was founded in 1998, we have worked with more than 20 managed care payor organizations of all sizes, helping them develop solutions specific to their business needs. Recently, we welcomed two new members to the IntelliClaim customer community.</p>

<p class="main"><font style="font:  bold;">Anthem West</font>, part of the Anthem, Inc., system of Blue Cross/Blue Shield plans, has signed on with IntelliClaim. In addition to our claim editing services, IntelliClaim will be working with Anthem to offer direct access to rule justification for members of their provider network – customized through Anthem’s own website. We expect the program to be up and running within 90 days.</p>

<p class="main"><font style="font:  bold;">Montefiore Healthplans</font>, a provider-owned organization covering 135,000 lives in the New York Metropolitan area, has engaged IntelliClaim for our full suite of solutions, including "roundtrip" integration of IntelliClaim’s technology with their claims processing system. With a commitment to meet a tight schedule, Montefiore was up and running in just 60 days.</p>

<p class="main">If you’d like to learn more about client solutions we have available, and how they might be customized for your needs, please contact <font style="font: bold;">Ed Brennan</font>, <a href="mailto:ebrennan@IntelliClaim.com">ebrennan@IntelliClaim.com</a>, 203-750-5145.</p>
		</td>   
		</tr>
		</table>
	</td></tr>
	<tr>
	<td valign="bottom" rowspan="2">
		<table width="140" border="0" cellspacing="0" cellpadding="0">
		<tr><td valign="bottom"><img src="http://www.aifarms.com/intelliclaim/newsletter/people.jpg" width="131" height="87" alt="" border="0"></td></tr>
		</table> 
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td colspan="2">
		<table cellspacing="0" cellpadding="0" width="100%">
		<tr>
		<td bgcolor="#00A9C6" width="100%"><a name="intelliclaim_people"><p class="head">IntelliClaim Welcomes New Chief Medical Officer and Data Analyst</p></td>   
		</tr>
		<tr>
		<td width="100%">
<p class="main">In June, we were proud to welcome Dr. Bruce Campbell as IntelliClaim’s new Chief Medical Officer.  Dr. Campbell will work with our clients to identify opportunities to improve their claims policies, to make the most of IntelliClaim’s technology to enhance their decision-making and to communicate their claims processes to providers.</p>

<p class="main"><font style="font: italic;">"IntelliClaim’s strategic approach and the depth of the company’s high-tech solutions appear to offer a great opportunity to secure higher efficiencies and strong provider relations throughout the industry," Dr. Campbell said. "I am delighted to be asked to participate in this effort, and I look forward to working closely with Kevin and my new colleagues."</font></p>

<p class="main">Dr. Campbell brings to IntelliClaim the experience and insight gained during a distinguished career in health benefits and medical management. Between 1994 and 1997, he held several executive positions with Aetna, Inc., including Senior Vice President of Aetna US Healthcare and Chief Medical Officer of Aetna Health Plans. Dr. Campbell served as Vice President for Medical Programs at ScrippsHealth and was President of Monsanto Health Solutions. Most recently, he served as President and CEO of Camber Companies, a multi-disciplinary musculoskeletal ambulatory treatment center business.</p>

<p class="main"><font style="font: italic;">"Bruce’s energy and expertise are a terrific asset for IntelliClaim’s clients,"</font> said CEO Kevin Hickey, <font style="font: italic;">"and his addition to the senior team is an important milestone in the growth of our business."</font></p>

<p class="main">This month also saw the addition of Daniel Sherman as data analyst at IntelliClaim.  As a data analyst, his primary responsibility is as a liaison between the client’s and the technical areas within IntelliClaim. A business systems professional with deep experience in the managed care environment, Dan joins IntelliClaim from HealthNet of the Northeast, one of the largest regional health plans serving over one million members.</p>
		</td>   
		</tr>
		</table>
	</td></tr>
	<tr>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td colspan="2" bgcolor="#FF371F" width="100%"><a name="customer_qa"><p class="head">Questions From Our Customers
</p></td>   
	</tr>
	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/q.gif" width="12" height="11" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
		<p class="question">Our providers often request additional information on clinical justifications for claim denials or adjustments. Where can we get this information?</p></td></tr>		
	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/a.gif" width="12" height="12" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
<p class="main">While details on clinical justifications are typically provided by the source of the rule or edit, access can be complicated. Individual vendors or associations may provide access to this information, but it may only be through a proprietary network or made available by doing further research. For example, in the case of the CMS CCI edits, justifications are available but the information may not be readily available or may reference other CMS publications, such as its carrier’s manual or numerous other program memoranda.</p>

<p class="main">At IntelliClaim, we maintain a database of the justifications aggregated from all of our various content sources – critical information that can be easily accessed by our customers through the Internet. You can also quickly forward this data or provide web access to either your own staff or to the interested provider.</p>
	</td></tr>		

	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/q.gif" width="12" height="11" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
		<p class="question">Our current corporate structure allows medical directors in each of our regions to modify payment policies to conform to regional standards. How can we accurately process claims that allow for such variation?</p>
	</td></tr>		
	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/a.gif" width="12" height="12" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
<p class="main">As payor organizations continue to grow, regional variations in payment policies will become even more complex, and have a greater impact on the bottom line. Indeed, once the variations are understood, your data may require customization at the level of payment logic to make the rules consistent overall, but also sensitive to regional differences.</p>

<p class="main">Fortunately, IntelliClaim’s customized solutions approach is designed precisely for these increasingly important market factors. In one instance, IntelliClaim worked with the payor organization to analyze the payment policy of each region. After interviewing each medical director, IntelliClaim identified those rules requiring customization in each region, and then proceeded to implement
through a technology solution that assured accuracy without manual intervention. The result for our customer: fewer appeals, less expensive reprocessing. And, as a significant additional benefit, regional variations were documented and authorized within the client's medical payment policy, thus providing a repository for policies and the exceptions, including a full audit trail of the origin and final decision.</p>
	</td></tr>		

	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/q.gif" width="12" height="11" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
		<p class="question">Is there a way to study the impact of a new rule before we decide to implement the rule in our processing system? Although we're looking for additional cost savings, I'm cautious about the possible impact a new rule may have on some of our providers.
</p>
	</td></tr>		
	<tr><td align="right" valign="top">
	<p class="qa"><img src="http://www.aifarms.com/intelliclaim/newsletter/a.gif" width="12" height="12" alt="" border="0"></p>
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td width="100%">
<p class="main">IntelliClaim customers have the ability to run a newly configured rule against existing claims data without the outcomes of these new rules being applied against the claim. At the same time, these outcomes are made available in a database against which reports can be generated, giving our client’s the ability to study the financial impact as well as the impact on specific providers, specialties, procedure codes, or any other attributes on the claim.


<p class="main"><font style="font: italic;">If you would like more information related to any of these questions, please contact</font> Sandy Slowik <font style="font: italic;">at</font> <a href="mailto:sslowik@intelliclaim.com">sslowik@intelliclaim.com</a><font style="font: italic;">, or call 203-750-5147.</font></p>
	</td></tr>		
	<tr><td>	
	</td>
	<td bgcolor="#676464"><img src="http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif" width="1" height="1" alt="" border="0"></td>
	<td colspan="2">
		<table cellspacing="0" cellpadding="0" width="100%">
		<tr>
		<td bgcolor="#00A9C6" width="100%"><a name="intelliclaim_pov"><p class="head">POV: Focusing on Transparency: A Defining Trend</p></td>   
		</tr>
		<tr>
		<td width="100%">
<p class="main">Today, all medical claims payors face a common challenge – they must provide clear and consistent justification of claims administration so that both providers and consumers can better understand the actions taken by payors. The payors must demonstrate to consumers, providers and policymakers that they have a solid commitment to consistent and accurate processing of claims.</p>

<p class="main">For this reason, providers often feel that they are kept in the dark about how a payor will ultimately decide which procedures to pay and which to deny. While remittance from a payor might provide a clear indication of what has been denied, the justification for that denial is not always clearly conveyed to a provider. Some providers will not accept the application of correct coding practices, regardless of the degree of justification or support, but the vast majority are accepting of payor decisions that are made with a thoughtful rationale and with consistent application.</p>

<p class="main">Communicating the rationale for payment decisions is not always a simple capability for a payor to enable.  Payors with system constraints struggle with the best way to communicate their payment decisions to providers. Legacy claims
systems do not always allow for flexibility in applying payment methodologies that take provider contracts into account. Moreover, communicating the outcomes of claims editing (such as "bundling") often requires that the procedure be denied first, an instance further complicated by the need to draw additional supporting documentation from sources external to the claims processing system.</p>

<p class="main">Industry trends, evolving state legislation (e.g., Georgia, Texas, New Jersey, New York, Colorado), and recent ERISA regulations indicate that these issues will only become more difficult. As payor organizations expand, state by state policy issues come into play, complicating the nature of information and how it can be shared. In addition to providing clearer direction and justification as to how a payor has reimbursed a claim, payors are being required to provide disclosure of those payment methodologies in advance.</p>

<p class="main">More is at stake in this "transparency" issue than simple administrative efficiencies. At IntelliClaim, we believe that better communication of claims decisions and justifications are crucial for enhancing provider relations and, ultimately, strengthening the image of our industry among consumers and policymakers.</p>

<p class="main">At IntelliClaim these emergent transparency issues are very much top-of-mind. Through both our advanced technology – grounded in the latest rules-based science of applied artificial intelligence – and our consulting services that support payor organizations at all levels, IntelliClaim looks for the smartest solutions, and the clearest path to productive transparency for our clients.</p>
		</td>   
		</tr>
		<tr>
		<td bgcolor="#7FC31C" width="100%"><a name="intelliclaim_in_the_news"><p class="head">Intelliclaim in the News</p></td>   
		</tr>
		<tr>
		<td width="100%">
<p class="main">Recent press coverage on an effort we have underway to enhance fraud and abuse detection with one of our clients, from <font style="font: italic;">ADVANCE for HEALTH INFORMATION EXECUTIVES.</font> 

<a href="http://www.advanceforhie.com/hxMCO.html">http://www.advanceforhie.com/hxMCO.html</a>

<p class="main">MCO Update: Fraud and Abuse Detection<br>
<font style="font: italic;">by Robert Mitchell</font></p>

<p class="main">Health plans regularly monitor physician-billing practices, often catching fraudulent activities after a claim has been paid. But health plans are now looking to catch these activities before it costs them any money. Health plans view this as a preventive solution that could reduce fraudulent activity from occurring in the first place.</p>

<p class="subhead">What is fraud?</p>

<p class="main">Grace Mary Altkin, manager of cost containment at Vytra Health Plans, a 200,000-member plan with 6,000 physicians and 38 hospitals on Long Island, said her company wanted to capture fraudulent activity before the health plan paid out any money. 
The health plan, which is piloting a fraud detection system by HNC Software of San Diego through a project with IntelliClaim, said it is exchanging data with HNC and has already gotten initial favorable results that could save money. <font style="font: italic;">"We have a fraud unit here and are identifying claims that need to be reviewed,"</font> Altkin said. <font style="font: italic;">"We're confident that we have the right systems and procedures in place, but there still may be some leakage . . . We want to identify any gaps, identify any trends and see if we can put in additional procedures to prevent us from paying incorrectly on fraudulent items or in paying incorrectly on abusive billing practices."</font></p>

<p class="main">Gayle Esposito, a senior investigator in Vytra's special investigative unit, said determining if a claim is fraudulent requires the health plan to look at whether the provider's actions constituted a legitimate mistake, neglect or actual fraud. <font style="font: italic;">"I look for trends,"</font> she said. <font style="font: italic;">"We regularly use adjustment codes and our provider relations representatives educate the providers; if a provider continues to do something he or she has been told not to do, then we feel the provider has crossed the line."</font></p>

<p class="main">Andrea Allmon, PhD, product director of HNC's predictive health care group, said, <font style="font: italic;">"There are providers who are genuinely good-hearted individuals, who want to maximize their clinic or office revenues so they may up-code a claim here or there. 
There are also providers who want to care for their patients but, because of perceived constraints on what insurance companies pay, might disguise a service so the insurance company pays for something that might not otherwise be covered."</font></p>

<p class="main">Akshay Gupta, chief business development officer at IntelliClaim, said the question of intent is always considered in reviewing whether a claim should be reimbursed or whether fraud or abuse occurred, or whether it was simply an error or oversight. 
<font style="font: italic;">"A lot of errors occur because of the way the health insurance industry works; it's extremely complicated. And when a provider works with many different health plans, each with its own set of rules on how to bill and what can be billed, it can be confusing. Physicians sometimes bill for everything they can and let the health plan sort it out," Gupta said. "We help health plans deal with that complexity more effectively today, and through HNC's sophisticated software will now be able to help them by proactively identifying abusive or fraudulent behavior."</font></p>

<p class="main">Steve Biafore, vice president of HNC Software's predictive health care group, noted that the General Accounting Office has said that managed care fraud and abuse is difficult to solve and, <font style="font: italic;">"it's commonly understood that there is about three percent hard-core fraud, to well over 10 to 14 percent losses due to fraud."</font> </p>

<p class="main">This is alarming because the government has projected national health expenditures to total $1.4 trillion and reach 13.4 percent of the Gross Domestic Product each year, according to National Health Care Expenditures Projections: 2000-2010 from the Office of the Actuary at the Center for Medicare and Medicaid Services. </p>

<p class="subhead">Risky claims</p>

<p class="main">Analysis information provided by HNC to Vytra includes a claim's risk score. HNC also supplies an explanation of why a particular claim may be considered risky. <font style="font: italic;">"A claim may be a risk because the provider's procedure mix is radically different from other providers or for other reasons,"</font> Allmon said. </p>

<p class="main">After a claim has been identified as risky, there are a couple of scenarios that can occur. <font style="font: italic;">"First, investigators can decide to pay the claim and watch what the provider does. Or, they can simply deny the claim,"</font> Allmon said. <font style="font: italic;">"They could also suspend the claim, request further information, or deny the claim and investigate further, thus possibly leading to prosecution of the provider."</font> </p>

<p class="main"><font style="font: italic;">Mr. Mitchell is senior associate editor of ADVANCE for Health Information Executives.</font> 
</p>
		</td>   
		</tr>
		</table>
	</td></tr>
	</table>
</td></tr>
</table>

</body>
</html>


------=_S96xdKnA_yxlVaFWs_MA--

------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/jpeg; name="intelliclaim_news_banner.jpg"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/intelliclaim_news_banner.jpg
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------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/gif; name="intelliClaim_logo_grey2.gif"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/intelliClaim_logo_grey2.gif
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==


------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/gif; name="blank1x1.gif"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/blank1x1.gif

R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==

------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/gif; name="grey1x1.gif"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/grey1x1.gif

R0lGODlhAQABAIAAAKakowAAACH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==

------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/jpeg; name="people.jpg"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/people.jpg

/9j/4AAQSkZJRgABAgAAZABkAAD/7AARRHVja3kAAQAEAAAAUAAA/+4ADkFkb2JlAGTAAAAA
Af/bAIQAAgICAgICAgICAgMCAgIDBAMCAgMEBQQEBAQEBQYFBQUFBQUGBgcHCAcHBgkJCgoJ
CQwMDAwMDAwMDAwMDAwMDAEDAwMFBAUJBgYJDQsJCw0PDg4ODg8PDAwMDAwPDwwMDAwMDA8M
DAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwM/8AAEQgAVwCDAwERAAIRAQMRAf/EAKgAAAID
AQACAwAAAAAAAAAAAAcIBQYJBAIDAAEKAQADAQEBAQEAAAAAAAAAAAAEBQYDAgcBABAAAQMD
AwIEBQIEBAUFAAAAAQIDBBEFBgASByExQSITFFFhFRYIcTKRIzMXgaHBQrHhUmJDJCU1NhgR
AAEDAgQDBAgFBAMBAAAAAAEAAgMRBCExEgVBUWHwcYETkaGxwdHhIhTxMkKCwlIjFQZikqJD
/9oADAMBAAIRAxEAPwDNjJb0zfVxJZUW5rO+O8wamjaTubIPagB2j9NPL2QSNB48Ui2yExuc
OHD11VbWy82EeqkpDidyagioPiO2g5W+WK800ipJgvE7QP8AXQ5kKI8sLoffdkllbu9W1pKA
tZru29DToNG3chcAUHaQhhIUlZ3243v3gQJAjqDCh3FQdxGu9udUu5rHcYqhvLipK2ZY62pC
JRUuKtoIqn/xqHTcK6PbfNa7Se3qS+TbC8VaMu3Nc18iN/y7nHeDzEw1KqGoURWpr8dCbhbg
UkBzRu3Tk1jcKUUji91MFm5Q3LXa5DF0juMJkT2GS4FkdCy+8CGyPjUfxpr5YOzBGC+bjFWh
BoR0UJdMekWqK3Kdlx1PvbS23EkMyUICqkBS2VrAV8j/AA0VLCIm6kLE/wA91AaqDKFrUC4s
rNANxNe366UvmLk4bbNauiLBTLf9vuKXXhti0oElyooFkkUBFevx1tB/cOnisLhgjGrgM18f
iuxHXIzyQl5hRSsA16j9NZTsMby0raAtlYHDJSNkgQrjLWzKWWmwytwOghIGwVJNf8tE2UQk
dRyE3B5iZqYopxlKHVpB3JSTtWQOo8D0J0POCx1EXbhr21X1sTTt+msdZRGgLtFpnPNRHxFI
YmLUzFkkBKFKR+4V+XjoqKKSQVGWSAmmijJaTiMeKN32bdvtWnqNV+xqV3KpX7or8P208dEf
499adfdXmhP8gzTXp/KnJAiWtozVpS3UJJr16k9euuJHAGtFtbg5L4j13A1HSQrzkpQRWlfg
aEjWDX+YPLRhboOtS8W2OyoN5ITGT9IQl+Qpa0JdUFLDYDY6KXQnqBXXYi/tvbxbT1lYun0y
sJ/VX1BTlriW+4Y7NU4Ahy3NqU48EgrSa1TQ0r5jpnbCOa1NeHfzSq7klhu26ePdyVKQhwBx
bIUnZUFwA06/Ej9dI4qxmoyT+Sj/AKSvAI3HoKqAJp26DudZsiLzgtHPDAr/AGKzfWMfkx2V
bnUBbhUeuxSST0SPjqls7YXFsW9s1Mbjem1uWu4fLuK7n8Nt0vErbPs92uV+ymv/AKqyNQgq
OzHHQBpxDq3FKCu4LaRoSXbD5ReDWnbmiYd2pMI3tpXrXhXkqbBt765HsZTLsVM+raHHG1JA
dbP/AHAdj0Oh7Iaj5buKNvJA1vmN4Ij4lhOETpzVgy3JJ9qv13CkWaTDjpXAYc2ko94tyjhC
lClGkmnx1q/bAyQMLsT0+aE/y7nRuka36W9flVCu5QnbXcZtvdcS49AfWyp1smhU2qm5Jp8u
ml72GN9DmE1jmErKjirO/ZWbhYBfWZNbktalSIalVKmx0qKeI05mshPB5oz7DmkUW4OguTCR
9Jy9p4KYslnu93AzuHjqEWGwzYzWTuW8bGWkOqCVLW2CothQqDQbR0oBUDQ0AILZMqZ+xEXL
mhroq1rl7U4ec8AzuacictfGNnjMTsVs4k3Sa0UmOU+nvajqUnu4ewHfTLcWwPY1xdRx6FJN
okuYZHNa2rR1H4pQ0cfz0hFmuEYQrtDdd964gbylLJovcaj/AJa+M21ro2tdhj24ol28ObI5
zcQB3UIz4KKyvfj0iJFhRmBDqXo5KSf5gG0qNCAa9+us72tsQG5LuxeLprnOOJRb+6JH2rXY
K/253ft/833TT+FNY/ffVXtlTktPsBop0/lXmlxvkGTa7tIZkpAWFlQp2UD2poO6gcxxa5HW
U7ZGhzV9wZLrEhv0VJSXfKSoV6d+msrBxa+iPu2hzQvRJBS+8Cd/nNVgjr1+WhLqrXlEQ4sC
sWHSfSvDFvcIEK8n2U5GzdVDnQKSP+oE9DoraZi2YNOTs0t3uIOt3SfqYKhOQjG7BgWCuvQY
irpBYCn7wxJQlapTLpAWk0SB5fD4a9Bito7OEgDDx4nxXkkl9Nuly1xd9WIyHAdwCTTKvt5y
7Ov40XPpkgB1DDoIUypRJLdSBWmoHc/IbKfJOHcfevWtlNy6AC5bR4rxHM/04ZUXPYbw/ZZ6
JDaqMueSSg9ig9K/qO+uNtvTBJ07dFvuliLmKnEZdqhED3S7DOZcxaQ9aHWwVCSiQ8Hy4og7
0lCklIHgB/z1Sva1mDFO27XSjVIakfhwXg3PeyJ5jGb1JmXJ55Y+iH1SpaJC1UASp0mgUo+Y
f69dZ/S/+27wWkzDEfNZhz68AujNLvcsTusezR2nbXf7ESiXIdZCX2Hen9NS0lSVJp+5NPlr
Ddr8x0ZGcR8uYX7Zdt83U+UYHIenkUP7rk95vRfcuz7E+TKX6kq4PRYxluLPdS5Pp+sonxJV
qcddyOzKpm2UTSC0ZdT8UbOBONJWcO3W4z3FW3ErOErv95dBU202VbUssoHVx95R2oQO5+Wn
23SeXHXMnIZKe3ZhlfQGgbmc80xPHbF/u+UZtxNw9aEwTyUpULIpb5RITDtTQLYbrt9NBCDV
xYBUVdEka1uoI2VklzHf7kJaXMsgEcOR7vetgOJOJbBw/hULELE4tamh6t4vLpq/JeP7lrWe
tAOgHgNS09wZn1Pgq23tmwM0hZ0/klguP8acuY3yWxbXpOF5BP8A/d4TO3+Y4kH3LaQVjyuJ
NetNVVhO+aHRX6x2HRSW4W7YJvMp9B9Z9qVLH7fxvf8AlLH7jmNkmRuPV3Zxy3wUkBPopWSh
p11RSFpBoFUIoNGXts6VgGbggbK6bC8mlGlN195cW/RfW+zMc9H6j62zbHp9B+tel6FK/s9T
zbPj1poP7U6vV46Ub903y614V8NdFljl0BcyamUlRc3pShkkVJdUT0IFe/hr7uFuZjWq22q4
8plCMlRltPR5JYkNqjvR3NrqVgApIND069tIWxmGQalSeaJoqtxXoJHbv/r10HJQuKKYMFNY
3cW7VebZMXGbdVHlIcCl1PY0pStO/wAtGbZMI5WkhAbpbumgc0GlRyT9XjOMYex0Tbu96dmu
bGyb5f6agOqUpRuPWnamvS/Njji8x5o0d68RdBcSXXkRNq89RhhXjh60imWTsem3JX2xbXIc
FAUd7qqKd8x82zrt79q6gb829w4+SKAd5r6V6/tEd3bRAXT9Tj0aKZ/04Hgq/GQhyTHbdcDT
a3UBbhFQASKkjx0qtQPNAOSc3JPlmiMmVQFw7jb5EN1pUebFUXHXVpaSpTaSry7iBUgdBq2v
Y/LLXDI+4BQmzXZla9jsC0+0lDKSiXMdROSr0HoyyWgk7lpIPiU9q6VOq7FUYpSiMGYMYzk3
EWN5q3f0Sc7tl1cs+SWl5aRIVFcQXIj2w+ZQG1aSoVp0BpoLc5vOArw+S+7Xbi3c7TgD80AT
2P6dNI1QJ9/xp5ytGJ8ezsKmYtab3doM9652V6bEW83HcdTt9d9sONpfWKqSjqNiex6kaotp
tBcigdSnStVI/wCwX7rH6izUD1pT1Gq0v/HmFxVMU9m2GRbFbcwuMBprIbRa1obDCqlS3TGW
pS2d5PWhI6aH3MSM/tuNQO5E7O6KUGVgoTwx6pj8lvkez2l+RNdKWwkqU0D+/p2J+Gl1rAZX
gBNLy5EUZLlkJzNkmS8tZXd2GJjj1jsbLzntis+0YZZSdzhTXaD4A01fR2sdtEGjMrzQ38l3
O55/KMPR4IJZNzJb8i4xw7CIlghNPYiXybgwsKkvu7iDQJSUoBFO9a6BiLW6pAanKmScStkk
LYtOluBrUH1KvfVr99rbvtp6v2P7yny+59u79nw8e3y0L9xJq/L+rmP6Ud9tHo/P+imR/rQI
ySddYE2DMgyVMekVFpSegCux/wAjrO7uHxEPBRNnbMmYWOGea473IavVth3x11lN0J9tc2go
BxxSRVDu35judBXsguIxL+rGvqA6Izb4jayOg/RhTxqTzPrVSKVJCdw6KFUfMVppNcMpR3Ap
5G4HDkrJi1iOS3OPZIqXzc57rbcD0WnHxuJodyGgVfDqNFWMUcpLXGh4HEoLcLiSBoe0ahxF
QPWmbwe2KErJ8Ay21FUksuMJjvoWlTbqQeqUFST0PUV7au7L62GJ2WC803sCKRl3H+ap8MKc
fgld9ozGvkiCtR9Jt56OCTSoqQOvWlSB11GxNbHOWcCvR5Huktw/iE2v4/YRlOW23KsWxptM
fIghhUWzNxotJ0Z1dHVyZztHE+nSoSkgU7DrptbtFmdTxQen4qevyb0aWHUTlhT4K4u8TQb/
AMjReE7xeLdCvVnLcl52YhcVl0kArbirPqLcV16Einy00nvopIqEYjv4+Cn7Tbri3uC9rsH0
rgP016pbuTcCn8dZvkmIz478f6TLWiK462W/cMV/lvJJA3JWmhBGlOoHEZKzjJAoc1VJFglZ
BGMq3Q5EyfCjpStlhBUFNtCgUQlP+0dNZXNo2VhLfzLmO9NvJR5+nt0qqPKgzIKkInRHoa3E
hbaHkKQSk9iNwFRpBNA+M/UMU+guWTCrDX0plvx6vmLYzbM3v8yKJGWwER27Ep6imW25AWlb
hQQdykFPSvxGn2xHVVvpUv8A7M3Tpd6PUpc5KI6/dwpCmnyor9wlSkK3HrWooRqrJFKBRHlH
VU5psuK+bsi5Awy8cdXdxMm+2pku2G5LK1PPMKqlTa1gKBKa9DUaVR27IrjXw4p1dXEk1mWc
caZKZye1Ytxnxe/aJTapmZZUVJcCFKSpwuJI2qSO6Wwa9R3+eti59xNh+Xt4oKOKOytwXYvG
JPyxCTPjPBbXcMwYsxCYVtL1ZUhSd61UPVKa+J1sy3EVdAX2e+MukSOzwGHwC1h+1sM+len9
Ob9L7L+h7diae1+q+pT9v/X10o+vV+/+Kd/29H7P5LDa/RG7rBW3DPqPJIdjmoA/xJ7dNEXU
bZ46NxK6sHvt31fgPxQydZdjLU3IACgASQagg+IOpOeEsdRWUEwe2q9KgQOx2DqB8NCySOcK
FatYBUhX/Csiz/FZb/2dlVxxF6W2h+TKgzXIXqISdyPUcaUmqR8CaaZW1nK+rcvQl11dwx/W
RX0plMbyqzSZUPkXOecrXcsqKdl1iPMXV64kpGxKd6IikOeUUrvA09stxihGlxqPH4KW3Pap
7ofQ2h4CoPtIQVgYpHu0DI6vNv3OVJMy1XJKCUrarUKQpQB61II+PfWkG1edE8V+rChp15V5
LC+302s8RIoypqPDnQnPkuWPnN+wC7wLja0pF9hBl+23d+m9lba9yiGhRJ30oa+FR46Fv7l8
DdDhWvHL1JrYWcdwRIw0AqSKE1r1qESuXOfX+VXMEz9FvjWTkjF3T9bkQG1NtOBpSSy4OtaG
hqKmlaV0EJAYmubm2uHf1RwtnCd7X/lcBQ93QLzyGXL5rTIzi8POR71PYSxKlbtvrvNJ27gC
eg6UCU9AOmqKzs47qGrcPT8lJbjvEu23Gl2LeJwFBTDgaq2cCctZnxli95i2vJoGNW6BMMK4
xfTiOPyVBXquqeaeQ466ko8tQQBWg66XwWsEjSJMxln7kyvb25je10OIdnkMh1RIuGY/jY3l
lhytm/WvJbl791+RbJ8CaIi4z4LRZ2KjlLKk7ipO89+56g65lu4rj6Hmh4Zr7BYT2dXsFWnF
2I95PE8Et1xxtfGPJeWYpMUEWvIra79EkuVCHY8golRFghJ60SE/r0roCyAhudJyPwTe+kdP
a6wMRX20VUt1wRJbcaCgpTDhQqtf+FNUdrOHCinNysiHB4y7dVO2m9S8YvFsyO3rX7y0SEPt
toqCoJPVPQgkEa6uG8VlauLgWUzV2zb8lJN1yd68tY9DuDqo4ZYcmla0xkKHmDTSVAbviVV0
um3dlu4NaK9a/JGxf6/JdMLpHU5CnwITAcAWROYODIlQREWoh1aG07UGvagHQacm6Hk6qUqp
kbafutBdUM6U6c0+X0yT9Mp6CP8A4f0qUT2+p1p276TeaNX7v4qm8k6P20/9LDWyttJtkZZk
JUlW4+UGv7j0NdF2LQIgUPuMjjNpAUXlcFqeLabeyhUgOIjClEJUVq8m4qIA8x7kgaB3VgcA
5mYr7k02Vz2FzZcAae/kmNsP488XyU37FchzS827keLavqFufjtQxjrbwbDio65KlrU6RXaS
C317Vp1WSbaXkOyr25pi3eGtBGdO3JLBkTarZEiwGV+snzNKlLTRZQg/tSaA7anRG4VghDGn
A/JcbaBPMXuFCPmqXqZVOr3hmVXO0S41tjpQ/Glu7EsqT5t6zRIBqKCp1R7LuskBDOB7vgpP
/Y9ggvWa35jv6dQmT504Ox/jri3F8nvF7cl8mZLM9x9CjqSpmPbVIUVFYHmqFFIB7HzfDXd+
fPrQZca+5dbXWANBdnwp70mKHlNpc9NZaDqShwg9FJ+B+Wk0bnsNAc0/kY14qeCYPje9ZPJs
8OxzIdvudjjtqasLZYQmY08696nkcZCXFbiaELJ+Apqo2lsjG1OA8FFb46J7qDF3j+CE+Twr
1ZskvNnvMQ+4tNxeXcrepG1CXCqit4TXuOlSdIrlzhKScQPBU1m1hhAGBPiohmHHnu3FbEpi
AzGaW/HamObVOJSf6aVAUK6Ht46DEYkJoaURbpnQhoIrWteFETL1e7xk2F4pdb/bJKnMNdZt
kHJUpVWRbitbjbS9w2qU0pKghQPXse2jWNdoEruH4IB72iUws/Vw9efzR2zL8e7vgeBWHkiJ
IFxx3I/TKpCART1Ub21lJrQK6jT+2lhdgw4+PvU/OLj/AOgw4Ze5BOMlMqWiGsVLoPfpUAdR
XRbX6naSh5YvKZ5jEH5zaWZstpCA0lDywlCeoAr8TqIvcJSrmyNYgVoF+KvO2G45Aawu9sSE
XOUuqJJDbbPfoAdyir/GmqO1l+5jDQaEcO1FIX8Js5nSEVaeNcvatP8A6jZPp1fWTt+3/e1q
n+j9QpXv8dYaH6v3U9S38xmn9lf/AEvz7Wm4sPxzGADbkZRQppI6n50Hx0Vbygt0rR8JDtSs
pjpkwpTTrYDLjSgoUqa06U+de2mJi1xlrhgkrp9E4cw1I+C47Ry5nGPOW9uP7ORdbIyiJj06
dEZfVb2gTRLDDiSwlZrUrW2pVeta9dSzp3sHl0+rvVf9pHIfNr9PcUwti5uwfLDb8Y/IjDMU
vVovSizM5AsFvMO921dNqXlS4qQh4pPdKQR8a9tfbiM6BqPgsbZ48w6RgONfcglzlw2OKb3b
5FivjeYcfZUyZuEZgwmjcuP03Nrp0DjdQFAfI9K6VSRFuacwTiTJVXi9jGn77JGSRTOSIqvp
cRKXKrk1qglTZTsSkjco1HToO+m+ysY55a7j80m/2B8jIg5nDPLpzTS27DLvyRfmJN/nFEKI
wlF1uTaCpLEVlNAhtBqK7RRIr37/AB1ZTWxiZhmvNrTdGzyEDIZnl6kpXIa8ctef3dOIwVxL
FBmg26BM/mL2NKFPVJJCiulVDt4ajbyIRy1C9KsZzLBQ9sVrj+MCcW5qdcyW44VaLPcsZYjK
sdzt8VtptSwin85sdVOdKg+Gjr2cwxN05OzSewthPO8Pzbke+vJLB+a/DVy4wvN55Bt2SNyL
RyfP9O7WR1qkhp5H80lLlCNhJPwPh10vExex2nCtKpqIGskZrx0k0PeO2az0BBAp20oeCCn7
SinjmUpmYjc8Gu12MZqY9Ebs7sxSlxoyFSKulI7NkbyontSumttdNMDo3+HpSS9s3C5ZKzrX
0dVqtzhkWNW/g3FOLbLfXcoLNrhtouyiFKkFlAIcKqAFPw032Xb3gl7hTt3qd/2Hd426Y2nn
z6dFnNg+LjLeVcQ43lyXLHJyWezDVdAkK9BDxpvSNwqemvu4XgtnEEfUEZtlv95EHNP0njT8
CvHn38cs44ZzedaZcR6849NdUqw5Qhr0WJKabthqopS4B3Tur8NI3ROuTqZxT2O5bbDS/h24
JZg8/GmJeaK2ZDC6gg0UkpPy11ETEvk4bMO9Nz/evMvtbf8AU3t/9tPY7t6u33Rs3d++3po/
786q9vy05JV/imaKdP5V5pcLS45HvEp5DS0NKKkbU9QST0Gv1s4tfqREsbZGaSiKyZDoStw+
lX9rfan8PHT1mt2JU/KYYiQ3HnmhtkcZUa7SQoqV6oDqSrpXd31K7vCWS9uSrtnuPNhHbiVK
sXqGxi30osJdkuuuKLyvMpCVH/amv+aj+gOiI7tjLXQc/mhJLF77vzBkKYeHep9jkDMJXH44
vnk3LFUPqvFhYkNblwnkhQcXGcpuCXK0UK7a+FewUUJdVpGeWKNmlDHBwdlmKZqa4CxeRmfI
1oxyIgGRclhtCyQn0x13LNSOgGjNokEDi53BLt/ifcRBjDQu+XNaj854zE4g4/ttjtzrLJuI
KJTtR6z6kgFVE9Onz092y++6kc93D8OSkd42sWUDYWfqrX28z7VkjyNZXFSF5C02v0pKwh9Q
T5QoioqaU8NCbrBU6052a6owR8vfVPV+G3Meb4bjT9isPEk/NYJebW9k1t2oDCXTtDbylpoS
kg/7unw0ufGJ2ta40GKYNlNu5z2ipwwWjPO34+M/kRxvZseuF1XhVxbns3RU0xxPcSfSUhbJ
SHWe+8dd3hpMLjy3kDEJ4bbzGAnA+lYGc18bf2h5Sy/jtMxy4R8el+nDmupCFusrAW2tSR0B
Ukg9NdSEOGoLSGrfpJQtUPh46wCKCejhq03rk9nEMcsjki5zC03CUKV9BLXRZWa+VKR4nXoF
nfMitA8nAdOvcvI902uW43Ex6cTSmI5d6Mv5i8Sr44/svY+P8fRIzESlyVZgyNsyRJ3pDccB
JqUpIqK176l5LmS/cZHZDt0Vxa2UW2MbEz3/ADWk12x+x5DxFZWea7PDudwiwok29RepSie2
kEqQUbTXd3A6dx20utfNM9I8/D3ppeeUICZBgO/3L8/mUYPfeT+Zszt+H2iHAC7m8WYSPSgx
mGtxCBTypSKDwGnLrV8shHIYpO2/jhiDq5kgDHH1Ivf/AJlz37c9t9Wxvf8Ab30Wv1aPt919
xe4pWvbb0/XprL/HvrSvHl0rzXX+Tborp/TXP/lTkgKLd7d4uemVu18g7AabRxae9BuuQ4Ur
QK62axSJZC30qaR33U7/AMe2m9vETmprcbxjceHboq5yVjLiGYFwt7Dkgt1ak7ElZp4KNNL9
9sCWgjP8OqP/ANV3lry5pwGFPX0QouNsuFpW23cojkRTyA4yXBQLSexSR0OpGezkhNHD2K7t
r6K4BLDWnf7wtBPxs/G2XzLiyL3Hu0VmNbbc7EclNJcdKXXarTGUhYQkqSaKXQkDt37UDL+K
3hbqFXY8/gpKbbbm7unlho2g5GvpIKisV4hwnE+PeXL7Hu0j+8PHeULhYVkMV12IVGNscKxE
dUlKUFJKSVg1qAO40vgifI/6R4ptczsjj+s4cvmhtjvI+T8w3pUXObxJvOalz0kNvp2hxlPg
gJohOzxSAOnX46ebXcxgeW7CimN9tJq+bHjXuHLmnqHD2AX/APH3IcNx64QbryJmq224dyKV
CNFXBfQ46r1yg/ymxVCnEAgqO0V0u3GeWWalKMb3cfWmmz2sNvDqJ1SO40Iyr4ZKJ/C3iq98
P5pm2OZvCRdG8hjQ1WS4QZKXYK1sqUp0+k4UOBSa03Fv/TS64hkY3UDgO5OLW4ie7S4YnvWn
d2yKNblswWyn3JaU85VQCY8dsVU65XsB4aVw25fUpvLcCPDivztfl/fGc6/ILLLxYYr8hqYq
HFit7Cp19TMdtncEJFarKagDTSW1dCdBzSm3vWzjzG5fA0QWxTDZuVu3uxRI0lOXwGlSYVrW
kp9RqMlSpLZSU7g4AAUj9RriK2DgRx4Laa+cwtIy49qLc38QrLxXgPDdqzWwNNMy7xCVIyC4
O1LjTjVQ80VL6japJqf9NcXLXzERsFGjsV8tCyFpmeauOZ9mWCA0LmHF8q5kv/LOXTCq344n
2eGWwnefL0C0IKaD41+OqKPbSIPLZxz7VUvLu7PuDJJmMuwCN2FcnT+bMkehsR/a4zBIUtCx
uU516bvD/DWc1oyxi1DFx7dV3bbhJuM+kijR4+4LNP8ANPjGbx1yq9frSl2NbsjR7hiQySij
n+8AppTQM7zIBK3PL0Jrbs8smE9/p7c0B6y/tX+o5/8ASvV7q/f90/u/X56X1NfH3JlpGnw9
6MUiNZZE1uQxIbQt8BxyO4pDfpqV3T17fp4auGOY81GHQ1HtXnThLG2jseooa/8AWqIdks8C
UhSnrpCiR20VcUXkbj8kprUn9NM2ODaUxKnblr5SdR0t60+RUNyHaLla8ZVPxqbbLgJdUykI
ksOy47fYER9+6p8SEmg0BuNzKGUjaa9x94TLZbC3EodM9pHAah1rk6qEH2FKvlvtD3JXKcfG
be3GWvHoFwZmvlTYPmTF3NtROp77X+/fUlK18jv7hoetB8F6FC9kTaxio6Vd8VqN+H2d27BO
FMjs2K45kGfHH335Vnudtssj0rm6+sAsJcimW2FtqPm89dvWnhoK6tGl7QXih6jD1o2yvnBj
iI3VGWBxx7knPIWQZxkmYZleMksi7DOuk5h7JrYqOuN7VSGgmO26yoJKVemBTf1V31UWMMUY
owg9xr7yo/c7iaU1kBHQinuCGmG4vjAySdMuN/hN7QZVyb92wu4rbFSI8doKKkqX2UdvlT1V
8D88tjX1aQXHtzWnnSuZRwIaOnyTh49lV8Frucax4dNecn2xtqyORQ+lqOhSihlaVsqSoNtg
K2UV5nNylEnprqa3YaVeB271jbXcoJpGT27kxvDOI2Xj9L+S5Jkbec8xXCEpTGPompmT4sfu
UBkLW6TX9xCe/QaR3r3TnQAWx8zl66ceqpdviZbjzHEPl4NBxH/WvDoufCLznl8zvLHMpgSb
LCuaAZ7cuM42qPGSSGgQ6hO1J+fQ6NuI4Y4W6CDStKH08UBZzXEtw/zAWg0rUZZ04BXC8xfx
1cvtgjpTgzebxUoRYZTsm3/ViAk7VN1X6rhIrTvpK10uurq+hP3ti8ujKU51SCc4YTi1g5ux
PLOG8wt15z+8XZxGQ4ja5LEhcd5opEhx9LDilNJcSpW9K0jso/IbtcXPBpQoZ7A1lK4IuczX
q8wuObfieBWmQ7iwa9S/5Da2lvwa1q6gym0lum+u7zad2zWl2px+rlx7eCQXkjwwMYDoxx4H
x7+qS+w2RufNjMS7pGhxlOAeq/IQ22mp7lRUB/npk0AZpNI4nBo7eK1p/HvHMKx/HUs49erZ
eZiyFT34UtiSoKPgr0lKpT56md2mke6hBA7vkq/Y7eKNmDgXdD8yqT+auMYjkXF7zl4vlns1
/tLnu7Ci4TI8V2Vt6Ossh1aSskGtE6Ds3kVFMCmV6wGhriFlJ7GD9sU91Gp9nU/qI/b9zV+P
auiKNr4+5D6naf2/yX//2Q==

------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/gif; name="q.gif"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/q.gif

R0lGODlhDAALALMAAOhrR/Kvk/jVw/3y7PS5n++ef+uFYvbMt+l0T/Gniep8We2NbPXCq/rf
0fvo3v///yH5BAAAAAAALAAAAAAMAAsAAAQ0cBhAKzUj2A2CropieRQiEIxQkUByUE1Bsazw
sYkKOFP3IY+DbfUpyDYBAsdCGCyWgMUgAgA7

------=_kymKzPFE_OQL8qx8a_MR
Content-Type: image/gif; name="a.gif"
Content-Transfer-Encoding: base64
Content-Location: http://www.aifarms.com/intelliclaim/newsletter/a.gif

R0lGODlhDAAMALMAAAOp4pvM7mi56MDd9P///7TY8szj9na+6u/2/I/I7TOt44LD66jS8Nfp
+Eex5QAAACH5BAAAAAAALAAAAAAMAAwAAAQ2kJhAKzUS6M0n/wDFLQknbkjjbCdwDEWptUXB
DGyAUoQy6wBBQVMQ/EAmHFIzIAwOgqj0RYgAADs=

------=_kymKzPFE_OQL8qx8a_MR--

